#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Identification of Novel Type 2 Diabetes Candidate Genes Involved in the Crosstalk between the Mitochondrial and the Insulin Signaling Systems


Type 2 Diabetes (T2D) is a highly prevalent chronic metabolic disease with strong co-morbidity with obesity and cardiovascular diseases. There is growing evidence supporting the notion that a crosstalk between mitochondria and the insulin signaling cascade could be involved in the etiology of T2D and insulin resistance. In this study we investigated the molecular basis of this crosstalk by using systems biology approaches. We combined, filtered, and interrogated different types of functional interaction data, such as direct protein–protein interactions, co-expression analyses, and metabolic and signaling dependencies. As a result, we constructed the mitochondria-insulin (MITIN) network, which highlights 286 genes as candidate functional linkers between these two systems. The results of internal gene expression analysis of three independent experimental models of mitochondria and insulin signaling perturbations further support the connecting roles of these genes. In addition, we further assessed whether these genes are involved in the etiology of T2D using the genome-wide association study meta-analysis from the DIAGRAM consortium, involving 8,130 T2D cases and 38,987 controls. We found modest enrichment of genes associated with T2D amongst our linker genes (p = 0.0549), including three already validated T2D SNPs and 15 additional SNPs, which, when combined, were collectively associated to increased fasting glucose levels according to MAGIC genome wide meta-analysis (p = 8.12×10−5). This study highlights the potential of combining systems biology, experimental, and genome-wide association data mining for identifying novel genes and related variants that increase vulnerability to complex diseases.


Vyšlo v časopise: Identification of Novel Type 2 Diabetes Candidate Genes Involved in the Crosstalk between the Mitochondrial and the Insulin Signaling Systems. PLoS Genet 8(12): e32767. doi:10.1371/journal.pgen.1003046
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1003046

Souhrn

Type 2 Diabetes (T2D) is a highly prevalent chronic metabolic disease with strong co-morbidity with obesity and cardiovascular diseases. There is growing evidence supporting the notion that a crosstalk between mitochondria and the insulin signaling cascade could be involved in the etiology of T2D and insulin resistance. In this study we investigated the molecular basis of this crosstalk by using systems biology approaches. We combined, filtered, and interrogated different types of functional interaction data, such as direct protein–protein interactions, co-expression analyses, and metabolic and signaling dependencies. As a result, we constructed the mitochondria-insulin (MITIN) network, which highlights 286 genes as candidate functional linkers between these two systems. The results of internal gene expression analysis of three independent experimental models of mitochondria and insulin signaling perturbations further support the connecting roles of these genes. In addition, we further assessed whether these genes are involved in the etiology of T2D using the genome-wide association study meta-analysis from the DIAGRAM consortium, involving 8,130 T2D cases and 38,987 controls. We found modest enrichment of genes associated with T2D amongst our linker genes (p = 0.0549), including three already validated T2D SNPs and 15 additional SNPs, which, when combined, were collectively associated to increased fasting glucose levels according to MAGIC genome wide meta-analysis (p = 8.12×10−5). This study highlights the potential of combining systems biology, experimental, and genome-wide association data mining for identifying novel genes and related variants that increase vulnerability to complex diseases.


Zdroje

1. PetersenKF, DufourS, BefroyD, GarciaR, ShulmanGI (2004) Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 350: 664–671.

2. PetersenKF, BefroyD, DufourS, DziuraJ, AriyanC, et al. (2003) Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 300: 1140–1142.

3. KelleyDE, HeJ, MenshikovaEV, RitovVB (2002) Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 51: 2944–2950.

4. LeeHJ, ChungK, LeeH, LeeK, LimJH, et al. (2011) Downregulation of mitochondrial lon protease impairs mitochondrial function and causes hepatic insulin resistance in human liver SK-HEP-1 cells. Diabetologia 54: 1437–1446.

5. Hernandez-AlvarezMI, ChielliniC, MancoM, NaonD, LiesaM, et al. (2009) Genes involved in mitochondrial biogenesis/function are induced in response to bilio-pancreatic diversion in morbidly obese individuals with normal glucose tolerance but not in type 2 diabetic patients. Diabetologia 52: 1618–1627.

6. BillingsLK, FlorezJC The genetics of type 2 diabetes: what have we learned from GWAS? Ann N Y Acad Sci 1212: 59–77.

7. ElstnerM, AndreoliC, KlopstockT, MeitingerT, ProkischH (2009) The mitochondrial proteome database: MitoP2. Methods Enzymol 457: 3–20.

8. BossiA, LehnerB (2009) Tissue specificity and the human protein interaction network. Mol Syst Biol 5: 260.

9. SchadtEE, MolonyC, ChudinE, HaoK, YangX, et al. (2008) Mapping the genetic architecture of gene expression in human liver. PLoS Biol 6: e107 doi:10.1371/journal.pbio.0060107.

10. RueppA, WaegeleB, LechnerM, BraunerB, Dunger-KaltenbachI, et al. (2009) CORUM: the comprehensive resource of mammalian protein complexes–2009. Nucleic Acids Res 38: D497–501.

11. SchellenbergerJ, ParkJO, ConradTM, PalssonBO BiGG: a Biochemical Genetic and Genomic knowledgebase of large scale metabolic reconstructions. BMC Bioinformatics 11: 213.

12. KanehisaM, ArakiM, GotoS, HattoriM, HirakawaM, et al. (2008) KEGG for linking genomes to life and the environment. Nucleic Acids Res 36: D480–484.

13. LeeDS, ParkJ, KayKA, ChristakisNA, OltvaiZN, et al. (2008) The implications of human metabolic network topology for disease comorbidity. Proc Natl Acad Sci U S A 105: 9880–9885.

14. FengX, GaetaML, MadgeLA, YangJH, BradleyJR, et al. (2001) Caveolin-1 associates with TRAF2 to form a complex that is recruited to tumor necrosis factor receptors. J Biol Chem 276: 8341–8349.

15. ChadeeDN, YuasaT, KyriakisJM (2002) Direct activation of mitogen-activated protein kinase kinase kinase MEKK1 by the Ste20p homologue GCK and the adapter protein TRAF2. Mol Cell Biol 22: 737–749.

16. TsouHK, SuCM, ChenHT, HsiehMH, LinCJ, et al. (2010) Integrin-linked kinase is involved in TNF-alpha-induced inducible nitric-oxide synthase expression in myoblasts. J Cell Biochem 109: 1244–1253.

17. ShinodaS, SkradskiSL, ArakiT, SchindlerCK, MellerR, et al. (2003) Formation of a tumour necrosis factor receptor 1 molecular scaffolding complex and activation of apoptosis signal-regulating kinase 1 during seizure-induced neuronal death. Eur J Neurosci 17: 2065–2076.

18. ChangL, KamataH, SolinasG, LuoJL, MaedaS, et al. (2006) The E3 ubiquitin ligase itch couples JNK activation to TNFalpha-induced cell death by inducing c-FLIP(L) turnover. Cell 124: 601–613.

19. KarinM, Ben-NeriahY (2000) Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu Rev Immunol 18: 621–663.

20. ReuterS, CharletJ, JunckerT, TeitenMH, DicatoM, et al. (2009) Effect of curcumin on nuclear factor kappaB signaling pathways in human chronic myelogenous K562 leukemia cells. Ann N Y Acad Sci 1171: 436–447.

21. SugataniT, HruskaKA (2005) Akt1/Akt2 and mammalian target of rapamycin/Bim play critical roles in osteoclast differentiation and survival, respectively, whereas Akt is dispensable for cell survival in isolated osteoclast precursors. J Biol Chem 280: 3583–3589.

22. YinMJ, ChristersonLB, YamamotoY, KwakYT, XuS, et al. (1998) HTLV-I Tax protein binds to MEKK1 to stimulate IkappaB kinase activity and NF-kappaB activation. Cell 93: 875–884.

23. PahlHL (1999) Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 18: 6853–6866.

24. Paz-PrielI, HoungS, DooherJ, FriedmanAD C/EBPalpha and C/EBPalpha oncoproteins regulate nfkb1 and displace histone deacetylases from NF-kappaB p50 homodimers to induce NF-kappaB target genes. Blood 117: 4085–4094.

25. SubramanianA, TamayoP, MoothaVK, MukherjeeS, EbertBL, et al. (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102: 15545–15550.

26. YangC, AyeCC, LiX, Diaz RamosA, ZorzanoA, et al. (2012) Mitochondrial dysfunction in insulin resistance: differential contributions of chronic insulin and saturated fatty acid exposure in muscle cells. Biosci Rep

27. BaumgartnerBG, OrpinellM, DuranJ, RibasV, BurghardtHE, et al. (2007) Identification of a novel modulator of thyroid hormone receptor-mediated action. PLoS ONE 2: e1183 doi:10.1371/journal.pone.0001183.

28. FrancisVA, ZorzanoA, TelemanAA (2010) dDOR is an EcR coactivator that forms a feed-forward loop connecting insulin and ecdysone signaling. Curr Biol 20: 1799–1808.

29. LinJ, PuigserverP, DonovanJ, TarrP, SpiegelmanBM (2002) Peroxisome proliferator-activated receptor gamma coactivator 1beta (PGC-1beta), a novel PGC-1-related transcription coactivator associated with host cell factor. J Biol Chem 277: 1645–1648.

30. MeirhaegheA, CrowleyV, LenaghanC, LelliottC, GreenK, et al. (2003) Characterization of the human, mouse and rat PGC1 beta (peroxisome-proliferator-activated receptor-gamma co-activator 1 beta) gene in vitro and in vivo. Biochem J 373: 155–165.

31. LelliottCJ, Medina-GomezG, PetrovicN, KisA, FeldmannHM, et al. (2006) Ablation of PGC-1beta results in defective mitochondrial activity, thermogenesis, hepatic function, and cardiac performance. PLoS Biol 4: e369 doi:10.1371/journal.pbio.0040369.

32. SonodaJ, MehlIR, ChongLW, NofsingerRR, EvansRM (2007) PGC-1beta controls mitochondrial metabolism to modulate circadian activity, adaptive thermogenesis, and hepatic steatosis. Proc Natl Acad Sci U S A 104: 5223–5228.

33. HindorffLA, SethupathyP, JunkinsHA, RamosEM, MehtaJP, et al. (2009) Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci U S A 106: 9362–9367.

34. VoightBF, ScottLJ, SteinthorsdottirV, MorrisAP, DinaC, et al. (2010) Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet 42: 579–589.

35. SegreAV, GroopL, MoothaVK, DalyMJ, AltshulerD (2010) Common inherited variation in mitochondrial genes is not enriched for associations with type 2 diabetes or related glycemic traits. PLoS Genet 6 doi:10.1371/journal.pgen.1001058.

36. ZegginiE, WeedonMN, LindgrenCM, FraylingTM, ElliottKS, et al. (2007) Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 316: 1336–1341.

37. ZegginiE, ScottLJ, SaxenaR, VoightBF, MarchiniJL, et al. (2008) Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet 40: 638–645.

38. StrawbridgeRJ, DupuisJ, ProkopenkoI, BarkerA, AhlqvistE, et al. (2011) Genome-wide association identifies nine common variants associated with fasting proinsulin levels and provides new insights into the pathophysiology of type 2 diabetes. Diabetes 60: 2624–2634.

39. SoranzoN, SannaS, WheelerE, GiegerC, RadkeD, et al. (2010) Common variants at 10 genomic loci influence hemoglobin A(C) levels via glycemic and nonglycemic pathways. Diabetes 59: 3229–3239.

40. SaxenaR, HivertMF, LangenbergC, TanakaT, PankowJS, et al. (2010) Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge. Nat Genet 42: 142–148.

41. ProkopenkoI, LangenbergC, FlorezJC, SaxenaR, SoranzoN, et al. (2009) Variants in MTNR1B influence fasting glucose levels. Nat Genet 41: 77–81.

42. DupuisJ, LangenbergC, ProkopenkoI, SaxenaR, SoranzoN, et al. (2010) New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet 42: 105–116.

43. International Consortium for Blood Pressure Genome-Wide (2011) AssociationS, EhretGB, MunroePB, RiceKM, BochudM, et al. (2011) Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature 478: 103–109.

44. SpeliotesEK, WillerCJ, BerndtSI, MondaKL, ThorleifssonG, et al. (2010) Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet 42: 937–948.

45. HeidIM, JacksonAU, RandallJC, WinklerTW, QiL, et al. (2010) Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution. Nat Genet 42: 949–960.

46. ChambersJC, ZhangW, SehmiJ, LiX, WassMN, et al. (2011) Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma. Nat Genet 43: 1131–1138.

47. PattiME, ButteAJ, CrunkhornS, CusiK, BerriaR, et al. (2003) Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1. Proc Natl Acad Sci U S A 100: 8466–8471.

48. MoothaVK, LindgrenCM, ErikssonKF, SubramanianA, SihagS, et al. (2003) PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 34: 267–273.

49. MoothaVK, HandschinC, ArlowD, XieX, St PierreJ, et al. (2004) Erralpha and Gabpa/b specify PGC-1alpha-dependent oxidative phosphorylation gene expression that is altered in diabetic muscle. Proc Natl Acad Sci U S A 101: 6570–6575.

50. YadavH, QuijanoC, KamarajuAK, GavrilovaO, MalekR, et al. (2011) Protection from obesity and diabetes by blockade of TGF-beta/Smad3 signaling. Cell Metab 14: 67–79.

51. SamaniNJ, ErdmannJ, HallAS, HengstenbergC, ManginoM, et al. (2007) Genomewide association analysis of coronary artery disease. N Engl J Med 357: 443–453.

52. RamosRR, SwansonAJ, BassJ (2007) Calreticulin and Hsp90 stabilize the human insulin receptor and promote its mobility in the endoplasmic reticulum. Proc Natl Acad Sci U S A 104: 10470–10475.

53. SawaT, ImamuraT, HarutaT, SasaokaT, IshikiM, et al. (1996) Hsp70 family molecular chaperones and mutant insulin receptor: differential binding specificities of BiP and Hsp70/Hsc70 determines accumulation or degradation of insulin receptor. Biochem Biophys Res Commun 218: 449–453.

54. StrangerBE, NicaAC, ForrestMS, DimasA, BirdCP, et al. (2007) Population genomics of human gene expression. Nat Genet 39: 1217–1224.

55. NicaAC, PartsL, GlassD, NisbetJ, BarrettA, et al. (2011) The architecture of gene regulatory variation across multiple human tissues: the MuTHER study. PLoS Genet 7: e1002003 doi:10.1371/journal.pgen.1002003.

56. YangJ, FerreiraT, MorrisAP, MedlandSE (2012) Genetic Investigation of ATC, (2012) et al. Conditional and joint multiple-SNP analysis of GWAS summary statistics identifies additional variants influencing complex traits. Nat Genet 44: 369–375.

57. PathmanathanS, HamiltonE, AtchesonE, TimsonDJ (2011) The interaction of IQGAPs with calmodulin-like proteins. Biochem Soc Trans 39: 694–699.

58. WhiteCD, BrownMD, SacksDB (2009) IQGAPs in cancer: a family of scaffold proteins underlying tumorigenesis. FEBS Lett 583: 1817–1824.

59. TekletsadikYK, SonnR, OsmanMA (2012) A conserved role of IQGAP1 in regulating TOR complex 1. J Cell Sci 125: 2041–2052.

60. NauertJB, RigasJD, LesterLB (2003) Identification of an IQGAP1/AKAP79 complex in beta-cells. J Cell Biochem 90: 97–108.

61. KaddaiV, GonzalezT, KeslairF, GremeauxT, BonnafousS, et al. (2009) Rab4b is a small GTPase involved in the control of the glucose transporter GLUT4 localization in adipocyte. PLoS ONE 4: e5257 doi:10.1371/journal.pone.0005257.

62. SackMN (2010) Rab4a signaling unmasks a pivotal link between myocardial homeostasis and metabolic remodeling in the diabetic heart. J Mol Cell Cardiol 49: 908–910.

63. BarrettJC, ClaytonDG, ConcannonP, AkolkarB, CooperJD, et al. (2009) Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet 41: 703–707.

64. SchaeferCF, AnthonyK, KrupaS, BuchoffJ, DayM, et al. (2009) PID: the Pathway Interaction Database. Nucleic Acids Res 37: D674–679.

65. PlanetE (2010) phenoTest: Tools to test correlation between gene expression and phenotype. Bioconductor R package version 1.0.0.

Štítky
Genetika Reprodukčná medicína

Článok vyšiel v časopise

PLOS Genetics


2012 Číslo 12
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Aktuální možnosti diagnostiky a léčby litiáz
nový kurz
Autori: MUDr. Tomáš Ürge, PhD.

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#